Felikss Mutulis

Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo**This work was supported by grants from the Swedish Medical Research Council (04X-05957), the Swedish Society for Medical Research, and the Estonian Science Foundation (Grant 3267); the Ants ja Maria Silvere ning Sigfried Panti Malestusstipendium Foundation (to A.K.); and the Swedish Institute (to I.M.).

Ants Kask, Felikss Mutulis, Ruta Muceniece et al. · Endocrinology · 1998 · 155 citations

Discovery of novel melanocortin₄ receptor selective MSH analogues

Helgi B. Schiöth, Felikss Mutulis, Ruta Muceniece et al. · British Journal of Pharmacology · 1998 · 137 citations · Full text

Selective Antagonist for the Melanocortin 4 Receptor (HS014) Increases Food Intake in Free-Feeding Rats

Ants Kask, Lembit Rägo, Felikss Mutulis et al. · Biochemical and Biophysical Research Communications · 1998 · 128 citations

Obesity, Nutrition, Appetite +12

The MC4 receptor mediates α-MSH induced release of nucleus accumbens dopamine

Jonas Lindblom, Baiba Opmane, Felikss Mutulis et al. · Neuroreport · 2001 · 104 citations

Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats

Anna Valeria Vergoni, Alfio Bertolini, Felikss Mutulis et al. · European Journal of Pharmacology · 1998 · 101 citations

Behavioral Sciences, Behavioral Neuroscience, Medicine +10